Riskpilot← Back to searchSign inGet full accessDoktor Galo AB
ABActiveOrg 5593791451Sjösalagatan 6General medical practice activities · NACE 8621Est. 20221 employees
Revenue 2025
SEK 497K
-41% vs 2024
EBITDA margin
29.4%
-66% vs 2024
Equity ratio
66.8%
Financial strength
Net profit 2025
SEK 115K
-61% vs 2024
| Revenue | SEK 497K | -41% |
| EBITDA | SEK 146K | -66% |
| Net profit | SEK 115K | -61% |
| Total assets | SEK 210K | -51% |
| Equity | SEK 140K | -56% |
| Employees | 1 | — |
Legal name
Doktor Galo AB
Org number
5593791451
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 maj 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Erbjuda vårdkonsult som läkare inom vård och omsorg.
Address
Sjösalagatan 6
Email
dr.hamza.galo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 355 | 2 001 | 846 | 497 |
| Staff expenses | −170 | −1 237 | −373 | −321 |
| EBITDA | 169 | 714 | 427 | 146 |
| Depreciation & amort. | −44 | −134 | −52 | — |
| EBIT | 125 | 580 | 375 | 146 |
| Net financials | — | −1 | −5 | −1 |
| Profit before tax | 125 | 579 | 371 | 145 |
| Tax | −26 | −119 | −76 | −30 |
| Net profit | 99 | 460 | 295 | 115 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 303 | 1 382 | 429 | 210 |
| Equity | 124 | 486 | 320 | 140 |
| Long-term debt | — | 296 | 0 | 0 |
| Short-term debt | 179 | 600 | 109 | 70 |
| Total debt | 179 | 897 | 109 | 70 |
EBITDA margin
29.4%
This company
15.8%
Market median
+86% vs market
20222025
Equity ratio
66.8%
This company
38.2%
Market median
+75% vs market
20222025
Return on equity
82.0%
This company
18.4%
Market median
+346% vs market
20222025
Net profit margin
23.1%
This company
8.1%
Market median
+185% vs market
20222025
Asset turnover
2.36×
This company
1.12×
Market median
+111% vs market
20222025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-05-05 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Galo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hamza Galo | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Sali Karboun | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |